H-VLDFAPPGA-OH

Ref. 3D-PP46838

Produktinformation

• Name: H-VLDFAPPGA-OH
• Synonyme: NH2-Val-Leu-Asp-Phe-Ala-Pro-Pro-Gly-Ala-OH

Beschreibung

Peptide H-VLDFAPPGA-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VLDFAPPGA-OH include the following: Proteolysis-targeting chimeras enhance T cell bispecific antibody-driven T cell activation and effector function through increased MHC class I antigen presentation in V Massafra, S Tundo, A Dietzig, A Ducret - The Journal of , 2021 - journals.aai.orghttps://journals.aai.org/jimmunol/article/207/2/493/234652 Analysis of the functional WT1-specific T-cell repertoire in healthy donors reveals a discrepancy between CD4+ and CD8+ memory formation S Schmied, E Gostick, DA Price, H Abken - , 2015 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/imm.12472 Impact of mature dendritic cells pulsed with a novel WT1 helper peptide on the induction of HLA"‘A2"‘restricted WT1"‘reactive CD8+ T cells S Kan, T Bito, M Shimabuku - International , 2020 - spandidos-publications.comhttps://www.spandidos-publications.com/10.3892/ijo.2020.5110 WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma RA van Amerongen, RS Hagedoorn - for Immunotherapy of , 2022 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214430/ Mechanism of action of DSP-7888 (adegramotide/nelatimotide) Emulsion, a peptide-based therapeutic cancer vaccine with the potential to turn up the heat on non N Suginobe, M Nakamura, Y Takanashi, H Ban - Clinical and , 2023 - Springerhttps://link.springer.com/article/10.1007/s12094-022-02946-0 Clinical grade production of wilms' tumor-1 loaded cord blood-derived dendritic cells to prevent relapse in pediatric AML after cord blood transplantation M Plantinga, V Lo Presti, CG de Haar - Frontiers in , 2020 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.559152 Sub-ambient pressure IR-MALDI ion mobility spectrometer for the determination of low and high field mobilities J Villatoro , M Zuhlke, D Riebe , T Beitz, M Weber - Analytical and , 2020 - Springerhttps://link.springer.com/article/10.1007/s00216-020-02735-0 Generation of WT1 peptide-specific T-cells out of healthy volunteer donors for adoptive immunotherapy after allogeneic stem cell transplantation G Weber, J Karbach, S Kuci, H Kreyenberg - Bone Marrow , 2009 - go.gale.comhttps://go.gale.com/ps/i.do?id=GALE%7CA198170695&sid=googleScholar&v=2.1&it=r&linkaccess=abs&issn=02683369&p=AONE&sw=w Targeting LAG-3 and PD-1 to enhance T cell activation by antigen-presenting cells FS Lichtenegger, M Rothe, FM Schnorfeil - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2018.00385/full CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function E Ruggiero, E Carnevale, A Prodeus - Science Translational , 2022 - science.orghttps://www.science.org/doi/abs/10.1126/scitranslmed.abg8027 The physiological interactome of TCR-like antibody therapeutics in human tissues E Marrer-Berger, A Nicastri, A Augustin - Nature , 2024 - nature.comhttps://www.nature.com/articles/s41467-024-47062-5 A de-risking experimental framework defines the physiological interactome of TCR-based therapeutics in human tissues E Marrer-Berger, A Nicastri , A Augustin, V Pulko - 2022 - researchsquare.comhttps://www.researchsquare.com/article/rs-1828302/latest Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1+ leukemias E Doubrovina, T Carpenter, D Pankov - Blood, The Journal , 2012 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/120/8/1633/30848 CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulins C Jost, D Darowski, J Challier, V Pulko, LJ Hanisch - MAbs, 2020 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/19420862.2020.1840709

• Marke: Biosynth